Editorials: Passage of stem cell bill a victory of science

The New York Times and The Washington Post called passage by the Senate of an unrestrictive embryonic stem cell bill a win for American science, but said its likely veto means science will still be denied the support of federal funding that should be freed for the research. The Times also said a White House-supported companion to the embryonic stem cell bill, also passed by the Senate, was a "poorly considered proposal."

View Full Article in:

NYTimes.com · Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC